Search Login Register

Melphalan (Alkeran) Summary

2640 relevant articles (305 outcomes, 443 trials/studies) found for this Drug

Description: An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.

Also Known As: Alkeran; L-PAM; Sarcolysine; 4-(Bis(2-chloroethyl)amino)phenylalanine; Mustard, Phenylalanine Show All >>

Key Diseases for which Melphalan is Relevant

  1. Neoplasms (Cancer) : 57 outcomes 71 studies in 561 results
  2. Multiple Myeloma : 53 outcomes 125 studies in 592 results
  3. Melanoma (Melanoma, Malignant) : 28 outcomes 43 studies in 282 results
  4. Sarcoma (Soft Tissue Sarcoma) : 22 outcomes 15 studies in 136 results
  5. Amyloidosis : 21 outcomes 16 studies in 125 results
Show All >>

Drugs Related to Melphalan

  1. Prednisone (Sone)
  2. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  3. Cyclophosphamide (Cytoxan)
  4. Etoposide (VP 16)
  5. Melphalan (Alkeran)
  6. Prednisolone (Predate)
  7. Vincristine (Oncovin)
  8. Dexamethasone (Maxidex)
  9. Doxorubicin (Adriamycin)
  10. Carmustine (FIVB)
Show All >>

Therapies Related to Melphalan

  1. Drug Therapy (Chemotherapy)
  2. Stem Cell Transplantation
  3. Combination Drug Therapy (Combination Chemotherapy)
  4. Bone Marrow Transplantation (Transplantation, Bone Marrow)
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.